Harlan Weisman - Tff Pharmaceuticals Interim Chairman
Insider
Harlan Weisman is Interim Chairman of Tff Pharmaceuticals
Age | 72 |
Phone | 817 438 6168 |
Web | https://tffpharma.com |
Harlan Weisman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Harlan Weisman against Tff Pharmaceuticals stock is an integral part of due diligence when investing in Tff Pharmaceuticals. Harlan Weisman insider activity provides valuable insight into whether Tff Pharmaceuticals is net buyers or sellers over its current business cycle. Note, Tff Pharmaceuticals insiders must abide by specific rules, including filing SEC forms every time they buy or sell Tff Pharmaceuticals'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Harlan Weisman over six months ago Acquisition by Harlan Weisman of 27480 shares of Tff Pharmaceuticals subject to Rule 16b-3 | ||
Harlan Weisman over six months ago Acquisition by Harlan Weisman of 44967 shares of Tff Pharmaceuticals subject to Rule 16b-3 |
Tff Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (1.0591) % which means that it has lost $1.0591 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.1351) %, meaning that it created substantial loss on money invested by shareholders. Tff Pharmaceuticals' management efficiency ratios could be used to measure how well Tff Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Tff Pharmaceuticals currently holds 115.25 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Tff Pharmaceuticals has a current ratio of 8.02, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Tff Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
TaiWei Ho | In8bio Inc | 48 | |
Gordon JD | Quoin Pharmaceuticals Ltd | 61 | |
Mark White | Annovis Bio | 69 | |
Michael Myers | Quoin Pharmaceuticals Ltd | 63 | |
Ana GarciaCollazo | Gain Therapeutics | N/A | |
BSc FRCPath | INmune Bio | 59 | |
Sandra Esq | Immunome | 51 | |
Corleen Roche | Immunome | 57 | |
Ray Lockard | Tscan Therapeutics | N/A | |
Raymond MD | INmune Bio | 69 | |
JD MSc | Cue Biopharma | 61 | |
Lawrence Lamb | In8bio Inc | 70 | |
Michael Alley | AN2 Therapeutics | N/A | |
William MBA | Tscan Therapeutics | 54 | |
Kenneth MD | Cue Biopharma | 64 | |
Denise Carter | Quoin Pharmaceuticals Ltd | 56 | |
Brian JD | Tscan Therapeutics | 55 | |
DVM MS | Lantern Pharma | N/A | |
MD FACP | AN2 Therapeutics | 77 | |
Rex CFA | Anebulo Pharmaceuticals | 64 | |
Gavin MacBeath | Tscan Therapeutics | 54 |
Management Performance
Return On Equity | -2.14 | ||||
Return On Asset | -1.06 |
Tff Pharmaceuticals Leadership Team
Elected by the shareholders, the Tff Pharmaceuticals' board of directors comprises two types of representatives: Tff Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tff. The board's role is to monitor Tff Pharmaceuticals' management team and ensure that shareholders' interests are well served. Tff Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tff Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Harlan Weisman, Interim Chairman | ||
Zamaneh MD, Chief Officer | ||
Kirk Coleman, Treasurer CFO | ||
Paul Manley, Head Affairs | ||
Anthony Hickey, Chief Officer | ||
Christopher Cano, COO Devel | ||
Dale Christensen, Head Devel | ||
Glenn Mattes, CEO Pres |
Tff Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tff Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -2.14 | ||||
Return On Asset | -1.06 | ||||
Operating Margin | (6.09) % | ||||
Current Valuation | (2.27 M) | ||||
Shares Outstanding | 4.44 M | ||||
Shares Owned By Insiders | 3.31 % | ||||
Shares Owned By Institutions | 24.37 % | ||||
Number Of Shares Shorted | 157.16 K | ||||
Price To Book | 0.09 X | ||||
Price To Sales | 0.24 X |
Pair Trading with Tff Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tff Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Tff Stock
If you are still planning to invest in Tff Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tff Pharmaceuticals' history and understand the potential risks before investing.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |